Tuvonralimab
Product Specifications
CAS Number
2417649-44-4
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation|||Apoptosis|||Cell Cycle/Checkpoint
Bioactivity
Tuvonralimab (PSB-205; QL1706), comprising a combination of Iparomlimab and Tuvonralimab [1], functions as a dual immune checkpoint inhibitor through its formulation of anti-PD-1 IgG4 and anti-CTLA-4 IgG1 antibodies.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
